With cancer immunotherapy transforming survival rates, new chapters cover immune-related adverse events (irAEs), CAR-T cell therapy complications, and molecular tumor boards. The hematology section has been redrawn to reflect the 5th edition WHO classification of hematolymphoid tumors.
Comprehensive updates on COVID-19 and other coronavirus infections. harrison internal medicine 22nd edition